SCHEMBL79539

SCHEMBL79539

CC(C)c1ccsc1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Formaldehyde SCHEMBL28362816 0.93 ALOX5 (0.47)
SCHEMBL826272 0.87 ALOX5 (0.40)
SCHEMBL30295390 0.83 ALOX5 (0.47)
SCHEMBL5002209 0.79
SCHEMBL15854170 0.79
SCHEMBL19718394 0.79
SCHEMBL2005698 0.79
SCHEMBL18827337 0.79 ALOX5 (0.44)
SCHEMBL1310355 0.79
SCHEMBL142218 0.79

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1732 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104507977-B Offset lithographic printing ink with water and filler content 太阳化学公司 2019-10-11 CN claimed
CN-121293704-A Antistatic flame-retardant polylactic acid 3D printing material and preparation method thereof 吉安职业技术学院 2026-01-09 CN disclosed
US-12435054-B2 Therapeutic compounds and methods of use GENENTECH, INC. (US) 2025-10-07 US disclosed
EP-4185386-B1 HETEROCYCLIC INHIBITORS OF TEAD FOR TREATING CANCER GENENTECH INC (US) 2025-01-08 EP disclosed
US-12043607-B2 HDAC inhibitors and therapeutic use thereof TANGO THERAPEUTICS, INC. (US) 2024-07-23 US disclosed
US-20240239811-A1 5-(5-(PIPERIDIN-4-YL)THIENO[3,2-C]PYRAZOL-2-YL]INDAZOLE DERIVATIVES AND RELATED COMPOUNDS AS MODULATORS FOR SPLICING NUCLEIC ACIDS AND FOR THE T REMIX THERAPEUTICS INC. 2024-07-18 US disclosed
US-20240239792-A1 MODULATORS OF BCL-2 OR BCL-2/BCL-XL AND USES THEREOF ASIA VISION LIMITED (CN) 2024-07-18 US disclosed
US-20240239772-A1 PROTEASE INHIBITORS AND METHODS OF USE THE CLEVELAND CLINIC FOUNDATION 2024-07-18 US disclosed
US-20240239772-A1 PROTEASE INHIBITORS AND METHODS OF USE THE CLEVELAND CLINIC FOUNDATION 2024-07-18 US disclosed
US-20240228491-A1 METHIONINE ADENOSYLTRANSFERASE INHIBITOR, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF SCINNOHUB PHARMACEUTICAL CO., LTD. (CN) 2024-07-11 US disclosed
EP-1031622-A1 Process for the production of low sulphur gasolines INSTITUT FRANCAIS DU PETROLE (FR) 2000-08-30 EP disclosed
EP-0725126-B1 Process for desulfurizing catalytically cracked gasoline NIPPON MITSUBISHI OIL CORP (JP) 2000-08-09 EP disclosed
EP-1002853-A1 Process for the production of low sulfur gasolines Institut Français du Pétrole (FR) 2000-05-24 EP disclosed
CN-1253993-A Production method of low-sulfur gasoline INST FRANCAIS DU PETROLE (FR) 2000-05-24 CN disclosed
EP-0725126-A1 Process for desulfurizing catalytically cracked gasoline MITSUBISHI OIL CO., LTD. (JP) 1996-08-07 EP disclosed
US-4795687-A POLYTHIENYLENE, POLYPRYRROLE OR POLYANILINE MATERIAL PREPARED BY OXIDATION POLYMERIZATION MITSUBISHI KASEI CORP. (JP) 1989-01-03 US disclosed
EP-0261837-A2 Electrically conductive material and a process for the preparation of same and secondary battery using the electrically conductive material Sanyo Electric Co., Ltd (JP) 1988-03-30 EP disclosed
US-4711742-A Solution processible forms of neutral and electrically conductive poly(substituted heterocycles) ALLIED CORPORATION (US) 1987-12-08 US disclosed
EP-0203438-A1 Solution processible forms of neutral and electrically conductive poly(substituted heterocycles) ALLIED CORPORATION (US) 1986-12-03 EP disclosed
EP-0173126-A1 Process for preparing novel dihydropyridine derivatives OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1986-03-05 EP disclosed